Editorial Article
Brain organoids and MEA tech reveal new epilepsy mechanisms
Neurological disorder research is evolving from single cells to complex networks thanks to 3D brain cultures and multielectrode arrays
News & Articles
25
Selected Filters:
Product News
Maestro MEA platform powers first stem cell cardiac safety assay in FDA ISTAND program
This assay uses hiPSC‑derived cardiomyocytes with Maestro MEA technology to measure electrophysiology across a functional cardiac syncytium
Industry News
Axion BioSystems announces the acquisition of the intellectual property and assets of CytoTronics
Axion BioSystems acquires high-throughput, high-density CMOS MEA technology from CytoTronics
Product News
Researchers gain early insights into CAR T efficacy with patient-derived glioblastoma organoids on Maestro Z
New frontiers in glioblastoma: Patient-derived organoids on Axion BioSystems’ Maestro Z impedance-based live-cell analysis system offer new insights into CAR T bioactivity and immunotherapy efficacy
Product News
STEMCELL Technologies and Axion BioSystems partner to streamline culture and analysis of excitable cells
Through this partnership, Axion and STEMCELL will enable scientists to examine the complex interactions between electrical cells in vitro, driving mechanistic disease research and propelling therapeutic development in neural and cardiac fields
Product News
New connected lab functionality that enables easy side-by-side visualization of imaging and bioelectronic data
Axion BioSystems' Maestro MEA and Z platforms now automatically link with Omni imagers, offering enhanced live-cell analysis
Industry News
NETRI launches NeuroFluidics MEA line in collaboration with Axion BioSystems
High-throughput organs-on-chip platforms for disease research and drug discovery in neurology and dermatology
